Volume | 433,169 |
|
|||||
News | - | ||||||
Day High | 208.56 | Low High |
|||||
Day Low | 206.36 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Teleflex Inc | TFX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
206.84 | 206.36 | 208.56 | 206.71 | 206.71 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
11,678 | 433,169 | US$ 207.39 | US$ 89,835,088 | - | 177.633 - 276.43 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 49,772 | US$ 206.71 | USD |
Teleflex Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.72B | 47.06M | - | 2.98B | 356.33M | 7.57 | 27.29 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Teleflex News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 208.67 | 212.56 | 205.26 | 208.15 | 315,093 | -1.96 | -0.94% |
1 Month | 225.80 | 227.06 | 205.26 | 212.98 | 261,879 | -19.09 | -8.45% |
3 Months | 245.57 | 256.85 | 205.26 | 225.37 | 278,875 | -38.86 | -15.82% |
6 Months | 184.45 | 257.85 | 177.633 | 225.98 | 275,736 | 22.26 | 12.07% |
1 Year | 263.03 | 276.43 | 177.633 | 228.03 | 282,882 | -56.32 | -21.41% |
3 Years | 444.59 | 449.375 | 177.633 | 275.83 | 329,122 | -237.88 | -53.51% |
5 Years | 281.14 | 449.375 | 177.633 | 300.95 | 294,258 | -74.43 | -26.47% |
Teleflex Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |